SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-005782
Filing Date
2017-08-03
Accepted
2017-08-03 09:01:09
Documents
51
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20170630x10q.htm 10-Q 1169896
2 EX-31.1 glyc-20170630ex311faa1e1.htm EX-31.1 18169
3 EX-31.2 glyc-20170630ex3123d3747.htm EX-31.2 17220
4 EX-32.1 glyc-20170630ex3215dca7a.htm EX-32.1 10279
  Complete submission text file 0001558370-17-005782.txt   4428501

Data Files

Seq Description Document Type Size
5 EX-101.INS glyc-20170630.xml EX-101.INS 922281
6 EX-101.SCH glyc-20170630.xsd EX-101.SCH 27528
7 EX-101.CAL glyc-20170630_cal.xml EX-101.CAL 28670
8 EX-101.DEF glyc-20170630_def.xml EX-101.DEF 127704
9 EX-101.LAB glyc-20170630_lab.xml EX-101.LAB 271930
10 EX-101.PRE glyc-20170630_pre.xml EX-101.PRE 228022
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 171003267
SIC: 2834 Pharmaceutical Preparations